These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 10329920

  • 1. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G.
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [Abstract] [Full Text] [Related]

  • 2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E, Carrara P, Morilla R, Matutes E.
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [Abstract] [Full Text] [Related]

  • 3. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J, Babusíková O.
    Neoplasma; 2004 May; 51(2):97-102. PubMed ID: 15190418
    [Abstract] [Full Text] [Related]

  • 4. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I, Kuliczkowski K.
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [Abstract] [Full Text] [Related]

  • 6. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J.
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [Abstract] [Full Text] [Related]

  • 7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 8. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ, Faria MT, Pinto AM, da Silva MR, Correia Júnior ME, da Costa RJ, Parreira AB.
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [Abstract] [Full Text] [Related]

  • 9. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B, Ferrer A, Larramendy ML, Galimberti S, Aalto Y, Casas S, Vilpo J, Ruutu T, Vettenranta K, Franssila K, Knuutila S.
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [Abstract] [Full Text] [Related]

  • 10. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [Abstract] [Full Text] [Related]

  • 11. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S, Tucci L, Levato D, Docimo C.
    Haematologica; 1997 Oct; 82(3):286-90. PubMed ID: 9234573
    [Abstract] [Full Text] [Related]

  • 12. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
    Sellitto A, De Fanis U, Romano C, Dalla Mora L, Guastafierro S, Tirelli A, Lucivero G.
    Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
    [Abstract] [Full Text] [Related]

  • 13. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
    Milosević D, Marinković M, Jelić S, Colović M, Spuzić I.
    Arch Immunol Ther Exp (Warsz); 1995 Oct; 43(1):23-9. PubMed ID: 8744680
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V, Capalbo S, Lapietra A, Pavone V, Guarini A, Specchia G.
    Haematologica; 1999 Mar 15; 84(3):212-7. PubMed ID: 10189384
    [Abstract] [Full Text] [Related]

  • 16. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M, Rodriguez-Justo M, Morilla R, Catovsky D, Matutes E.
    Haematologica; 2000 Nov 15; 85(11):1140-5. PubMed ID: 11064465
    [Abstract] [Full Text] [Related]

  • 17. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G, Cannizzo E, Zucca A, Buda G, Orciuolo E, Marini A, Petrini M.
    Leuk Res; 2008 Feb 15; 32(2):263-7. PubMed ID: 17692374
    [Abstract] [Full Text] [Related]

  • 18. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1996 Feb 15; 81(5):428-33. PubMed ID: 8952156
    [Abstract] [Full Text] [Related]

  • 19. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 15; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 20. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.
    Tabernero MD, San Miguel JF, Garcia JL, Garcia-Isidoro M, Wiegant J, Ciudad J, Gonzalez M, Rios A, Raap A, Orfao A.
    Cytometry; 1995 Sep 15; 22(3):217-22. PubMed ID: 8556953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.